Explore our top-tier synthesized peptide catalog manufactured under strict quality standards.
Sermorelin Acetate (GRF 1-29 NH2) represents the amino-terminal fragment of naturally occurring Growth Hormone-Releasing Hormone (GHRH). Understanding the global market requirements is pivotal for B2B supply stability.
With clinical interest leaning away from exogenous rhGH injections due to tachyphylaxis risks, Sermorelin offers a physiological pathway by stimulating endogenous pituitary release. Global pharmaceutical companies and clinical compounding networks in North America, Europe, and the APAC region are drastically increasing multi-kilogram contract volumes for premium Sermorelin Acetate.
Global regulatory regimes mandate comprehensive analytical characterization. Synthetic Sermorelin (29 amino acids, molecular weight ~3458.05 g/mol) requires advanced monitoring for deamidation variants, truncated peptides, and beta-aspartate formation. Ensuring purity above 98.0% by RP-HPLC and strict bacterial endotoxin limits (< 5 EU/mg) is a baseline for industrial qualified batches.
Procurement executives are shifting from transactional spot buys to integrated CDMO collaborations. Custom counter-ion substitution (Acetate vs. Trifluoroacetate), lyophilized cake optimization for rapid reconstitutability, and sterile-fill ready Bulk Drug Substances (BDS) are reshaping how Sermorelin procurement workflows are structured internationally.
Hangzhou Thinheal Pharma-Tech combines localized chemical raw material synthesis chains with cutting-edge automated peptide synthesis lines.
Thinheal operates close to the foundational chemical supply chains in Zhejiang and Jiangsu. High-purity Fmoc-protected amino acids, specialized coupling reagents (HBTU, HATU, PyBOP), and CTC/Wang resins are sourced directly with audited quality trails, bypassing distributor markups and mitigating international lead times.
Our automated large-scale solid-phase peptide synthesis (SPPS) and liquid-phase fragment condensation platforms handle multi-ton commercial yields. With dynamic solvent recycling systems and high-throughput preparative axial-compression HPLC columns (up to 300mm ID), we guarantee unparalleled lot-to-lot batch consistency.
Our analytical laboratories deploy ultra-high-performance liquid chromatography (UHPLC) coupled with High-Resolution Q-TOF Mass Spectrometry. We provide global regulatory support files including DMF preparation, ICH Q1A stability validation, trace elemental impurity screening (ICP-MS), and GC residual solvent compliance.
From human endocrine research to animal healthcare protocols, Sermorelin serves distinct downstream commercial sectors.
Compounding pharmacies utilize lyophilized Sermorelin vials to optimize biological growth hormone output in adults experiencing age-associated somatopause, maintaining lean body composition and muscular recovery.
Acts as an intravenous diagnostic agent to evaluate pituitary somatotrope reserve function, determining whether growth hormone deficiency is hypothalamic or secondary to anterior pituitary failure.
Applied in canine and equine geriatric care protocols to stimulate metabolic vitality, mitigate sarcopenia, and support connective tissue rehabilitation without deregulating insulin sensitivity.
Widely formulated alongside GHRP-2, GHRP-6, or Ipamorelin. Sourcing dual-active or co-lyophilized peptide matrices requires refined chemical compatibility screening and dissolution stability protocols.
Thinheal operates an auditable, five-stage methodology engineered to eliminate synthesis side-reactions and guarantee chemical purity.
| Test Parameter | Standard Acceptance Criteria | Analytical Methodology | Thinheal Batch Consistency |
|---|---|---|---|
| Appearance | White or almost white lyophilized powder | Visual inspection | Conforms (Crisp, uniform cake) |
| Identification (MS) | 3458.05 ± 1.0 Da | ESI-MS / MALDI-TOF | Conforms (Monoisotopic matched) |
| Purity (RP-HPLC) | ≥ 98.0% (Single Max Impurity < 1.0%) | Reverse Phase HPLC (C18) | Typical 98.8% – 99.4% |
| Peptide Content | ≥ 80.0% | Nitrogen analysis / Elemental / UV | 83.5% – 86.0% |
| Acetate Counter-Ion | 3.0% – 10.0% | Ion Chromatography (IC) | 5.4% (Custom tailored upon request) |
| Bacterial Endotoxin | < 5.0 EU/mg | LAL (Chromogenic Kinetic) | < 0.5 EU/mg (Aseptic standard) |
Insights into shifting international procurement behaviors, cold-chain logistical security, and regulatory landscapes.
Early peptide synthesis relied on Trifluoroacetic acid (TFA) salts. Today, global therapeutic programs enforce strict counter-ion replacement to Acetate or Hydrochloride to eliminate cytotoxicity in in vitro cell applications and patient pain at injection sites during clinical administration.
Lyophilized Sermorelin requires continuous climate protection during export transit. Thinheal provides temperature-controlled validated packaging (-20°C gel blocks or dry ice with real-time USB/Bluetooth dataloggers) to assure peptide structural integrity upon arrival in Europe or the US.
Procurement teams require comprehensive Certificates of Analysis (CoA) containing raw chromatogram integrations, mass spectra, moisture determinations (Karl Fischer), and residual TFA thresholds (< 0.1%). We provide batch-level auditable documentation with every shipment.
Get rapid clarity on MOQ, lead times, regulatory compliance, and stability parameters for Sermorelin custom quotes.
Sermorelin is a synthetic peptide consisting of the first 29 amino acids of human Growth Hormone-Releasing Hormone (GHRH), with an amidated carboxyl terminus: H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2. It retains the full biological potency of native 44-amino acid GHRH while exhibiting increased synthetic yield and stability.
For custom research and pilot development batches, our MOQ begins at 100 milligrams to 1 gram. For commercial B2B supply, standard campaigns range from 100 grams up to multi-kilogram batches. Typical pilot turnaround is 2–3 weeks, while kilogram commercial synthesis cycles generally require 4–6 weeks inclusive of analytical QC release testing.
Yes. While standard solid-phase cleavage yields Trifluoroacetate (TFA) salts, Thinheal operates dedicated preparative ion-exchange columns to perform thorough salt conversion to pharmaceutical-grade Acetate salt. Residual TFA content can be guaranteed below 0.1% or non-detectable depending on end-user specifications.
Every lot is delivered with a complete Certificate of Analysis (CoA) encompassing: RP-HPLC chromatograms (purity & related substances), High-Resolution Mass Spectrometry (HRMS/ESI), Residual Solvent testing via Gas Chromatography (GC-HS), Bacterial Endotoxin testing (LAL assay), Karl Fischer Water Titration, and Counter-ion Determination.
Lyophilized powder should be stored under desiccated conditions at -20°C (or -80°C for long-term storage spanning multiple years) protected from light. Vials must equilibrate to ambient temperature prior to opening to avoid condensation. Once reconstituted with bacteriostatic or sterile water, solutions should be kept at 2–8°C and utilized within defined stability windows.
Complementary synthetic peptide APIs produced with our proprietary multi-ton synthesis capabilities.
Direct factory access with Hangzhou Thinheal Pharma-Tech Co., Ltd. Share target purity specifications, custom batch quantities, and target shipping destination. Our technical sales engineering team provides formal quotation breakdowns and batch feasibility dossiers within 24 working hours.
Thin
